Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

Morning Digest | Quad leaders meet in Tokyo at 2nd in-person summit; India to be the leader of green hydrogen, says Puri in Davos, and more

A select list of stories to read before you start your day

The Hindu

What's next for COVID-19 vaccines for youngest US children

Parents hoping to get their youngest children vaccinated against COVID-19 have some encouraging news

The Independent UK

What happened to the AstraZeneca vaccine? Now rare in rich countries, it’s still saving lives around the world

The AstraZeneca vaccine, developed in partnership with the University of Oxford, was one of the first vaccines available for use in the UK and around the world during the COVID pandemic.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

Biohaven's Neurological Disease Candidate Flunks In Late-Stage Study

Biohaven Pharmaceutical Holding Co Ltd (NYSE:BHVN) has announced topline Phase 3 results of troriluzole in patients with spinocerebellar ataxia (SCA). The primary endpoint measured the change in the severity of symptoms among patients from the baseline to week 48 of treatment. It did not reach statistical significance in the overall SCA population as…

Benzinga

Pfizer COVID shot seems protective for children under 5 in early data

Pfizer Inc. and BioNTech SE said their COVID-19 vaccine was highly effective and prompted a strong immune response in children under age 5, based on early results from a trial that is likely to pave the way for infants and toddlers to finally get immunized.

Tribune News Service

Covid vaccine: Pfizer says three doses enough to protect children under 5

Three doses of Pfizer’s Covid-19 vaccine will offer strong protection for children younger than 5, the company announced on Monday.

Evening Standard

If Pfizer's data pans out, when will little kids get the COVID-19 vaccine?

Pfizer plans to submit new data to the Food and Drug Administration this week, bringing families with young children one step closer to a long-awaited vaccine.

WEKU

Read news from The Economist, FT, and more,
with one subscription

Pfizer/BioNTech say 3 COVID shots elicit good response in children under 5

Drugmakers Pfizer Inc and BioNTech SE said on Monday that three doses of their COVID-19 vaccine generated a strong immune response in children under age 5 and was safe and well-tolerated in their clinical trial.

Reuters

Pfizer says 3 COVID shots protect children under 5

Pfizer says three small doses of its COVID-19 vaccine protect kids under 5 and that it plans to give the data to U.S. regulators later this week

The Independent UK

Pfizer says COVID vaccine more than 80% effective in kids under 5

Pfizer reported three doses of its vaccine in kids under five produced a strong immune response and was safe.

Axios

Coronavirus FAQ: I took Paxlovid. I felt better. Then symptoms rebounded. What's up?

The antiviral drug is prescribed to those at risk of severe disease. It's been credited with reducing hospitalizations. But then there's the "Paxlovid rebound."

WEKU

This Is What Whales Are Betting On Pfizer

Someone with a lot of money to spend has taken a bullish stance on Pfizer (NYSE:PFE). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

CDC Recommends Pfizer/BioNTech COVID-19 Booster Shots For Kids Aged 5-11 Years

The Centers for Disease Control and Prevention recommended that children ages 5 to 11 receive the newly authorized COVID-19 booster shot from Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX). Following the recommendation, many of the nation's doctors, pharmacies, and other vaccination sites are expected to begin offering the extra doses to the 28 million U.S. children…

Benzinga

High blood pressure tablets recalled in Scotland amid 'impurity' concerns

Twelve batches of Pfizer Accupro have been removed from the shelves.

Daily Record

Get all your
news in one place.

100's of premium titles.
One news app.

WEKU

The CDC is urging a Pfizer booster for children ages 5 to 11

The Centers for Disease Control and Prevention's advice opens a third COVID-19 shot to healthy elementary-age kids — just like what is already recommended for everybody 12 and older.

Al Jazeera

US panel recommends COVID booster jab for children aged 5 to 11

Just more than 29 percent of US children in the age group have received two doses of Pfizer-BioNTech’s vaccine to date.

Tribune News Service

CDC experts recommend COVID vaccine boosters for kids 5-11

The Centers for Disease Control and Prevention’s vaccine expert panel Thursday recommended kids 5-11 get a third shot of Pfizer’s COVID-19 vaccine as a booster five months after their last dose, which once adopted by the agency clears the way for pharmacies and health care providers to begin offering the…

The Independent UK

CDC advisers urge Pfizer booster for children ages 5 to 11

U.S. health advisers are urging a booster dose of Pfizer's COVID-19 vaccine for kids ages 5 to 11

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Pfizer, NIH Mulling Study For Longer Paxlovid Course To Combat Reinfections

The U.S. National Institutes of Health and Pfizer Inc (NYSE:PFE) are discussing testing a longer course of COVID-19 antiviral treatment Paxlovid, required to prevent reinfections, White House Chief Medical Officer Anthony Fauci said. "We're going to be planning what studies we're going to be doing relatively soon, within the next few days," to…

Benzinga

Read Why Pfizer Is Limiting Supply Of Paxlovid For Combination Studies: Bloomberg

Amid rising concerns over the potential development of resistance to Pfizer Inc's (NYSE:PFE) COVID-19 pill Paxlovid, the company has declined to supply researchers with the antiviral for use in combination studies, according to a Bloomberg report. Researchers say that Paxlovid combined with other drugs might stave off resistance. Pfizer hasn't started any combination…

The Guardian - UK

At least 25m people in UK to be offered COVID booster this autumn

Vaccine body says extra jab will be for most vulnerable adults, frontline social care and health workers

Benzinga

Upcoming U.S. FDA Decision A Potentially Major De-Risk Event For Revive Therapeutics

It’s been a long and arduous road for Revive Therapeutics Ltd. (OTC: RVVTF) regarding their Phase 3 clinical trial to evaluate the safety and efficacy of Bucillamine to treat COVID-19.

Benzinga

Looking At Pfizer's Recent Whale Trades

Wales Online

Heartbroken family of man take legal action after he died of blood clots two weeks after getting AstraZeneca jab

Jack Hurn had just bought his first home with his partner, and was planning on proposing to her

Tribune News Service

Q&A: A parents’ guide to COVID booster shots for kids 5-11

SAN JOSE, Calif. -- With COVID-19 cases rising again in the Bay Area, parents have a new consideration for protecting their children this week: The Food and Drug Administration granted emergency use authorization Tuesday for kids ages 5-11 to get a booster shot of Pfizer’s COVID-19 vaccine.

1 … 51 52 53 54

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

339 stories

Centers for Disease Control and Prevention

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.